Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT – Get Free Report) was the recipient of a significant decrease in short interest in the month of June. As of June 15th, there was short interest totaling 11 shares, a decrease of 84.1% from the May 31st total of 69 shares. Based on an average daily volume of 1,322 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.0% of the company’s shares are sold short.
Institutional Investors Weigh In On Innovator IBD Breakout Opportunities ETF
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Osaic Holdings Inc. lifted its stake in shares of Innovator IBD Breakout Opportunities ETF by 39.7% in the 2nd quarter. Osaic Holdings Inc. now owns 2,102 shares of the company’s stock valued at $77,000 after purchasing an additional 597 shares during the last quarter. Comprehensive Wealth Management LLC boosted its stake in Innovator IBD Breakout Opportunities ETF by 122.0% during the fourth quarter. Comprehensive Wealth Management LLC now owns 23,403 shares of the company’s stock worth $850,000 after buying an additional 12,859 shares during the period. Finally, Susquehanna International Group LLP increased its position in shares of Innovator IBD Breakout Opportunities ETF by 42.6% during the third quarter. Susquehanna International Group LLP now owns 26,176 shares of the company’s stock valued at $1,020,000 after acquiring an additional 7,817 shares during the last quarter.
Innovator IBD Breakout Opportunities ETF Price Performance
NYSEARCA:BOUT opened at $48.85 on Friday. The company’s 50-day moving average is $46.06 and its two-hundred day moving average is $41.49. Innovator IBD Breakout Opportunities ETF has a 1-year low of $35.05 and a 1-year high of $49.41. The firm has a market capitalization of $17.10 million, a price-to-earnings ratio of 28.69 and a beta of 1.04.
Innovator IBD Breakout Opportunities ETF Company Profile
The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.
Featured Articles
- Five stocks we like better than Innovator IBD Breakout Opportunities ETF
- BlackBerry’s Rally Is Running on a Bigger AI Story Than Earnings Alone
- MDA Space Targets US Defense Market With $620M Acquisition
- Carnival’s Second Quarter: Is the Stock Still Complicated?
- Domino’s Stock Slides to 52-Week Low as Investors Digest CEO Change
Receive News & Ratings for Innovator IBD Breakout Opportunities ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovator IBD Breakout Opportunities ETF and related companies with MarketBeat.com's FREE daily email newsletter.
